Substituted thiazole or oxazole P2X7 receptor antagonists
US10167281B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2017 |
| Grant date | Jan 1, 2019 |
| Priority date | — |
| Expiry date | Jun 18, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to novel substituted thiazole and oxazole compounds of formula (I) having P2X7 receptor (P2X7) antagonistic properties:The compounds are useful in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.